Skip to content
value.today

Intelligent Retinal Imaging Systems, Inc.

🇺🇸 Pensacola, Florida, USAHealth CareFounded 2017
Total raised
$13 M
2 rounds on record
Latest round
$4 M
Nov 2019
First round on record
Jun 2017
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Intelligent Retinal Imaging Systems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2019$4 MNo. 2$2 to $10 million

Intelligent Retinal Imaging Systems, Inc.: Raise no. 2, Nov 2019

Investors in this round

6 investors had bought by the notice of Nov 26, 2019: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $8 M offered; $4 M still to sell
Smallest investment taken
$44,884
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Annette Ramsey · Executive Officer
  • Steve Martin · Executive Officer, Director
  • Sunil Gupta · Executive Officer, Director
  • Jeff Stolte · Director
  • Matt Rice · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Martin, Ceo. Source: SEC Form D, newest notice filed Nov 26, 2019. Read the notice at the SEC.

equitySEC
Jun 2017$9 MNo. 1$2 to $10 million

Intelligent Retinal Imaging Systems, Inc.: Raise no. 1, Jun 2017

Investors in this round

4 investors had bought by the notice of Jun 30, 2017: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $10 M offered; $1 M still to sell
Smallest investment taken
$107,493
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Crawford · Executive Officer, Director
  • Sunil Gupta · Executive Officer, Director
  • Jeff Stolte · Director
  • Matt Rice · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jason Crawford, CEO & Secretary. Source: SEC Form D, newest notice filed Jun 30, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Intelligent Retinal Imaging Systems, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2019).

    SEC Form D · Nov 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2019

That is all the official record says: Intelligent Retinal Imaging Systems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Intelligent Retinal Imaging Systems, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Intelligent Retinal Imaging Systems, Inc.
NameRoleNamed in
Annette RamseyExecutive officerNov 2019
Steve MartinExecutive officerNov 2019
Sunil GuptaExecutive officerNov 2019
Jason CrawfordExecutive officerJun 2017
Jeff StolteDirectorNov 2019
Matt RiceDirectorNov 2019
Steve MartinDirectorNov 2019
Sunil GuptaDirectorNov 2019
Jason CrawfordDirectorJun 2017